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John Appleby
chief economist, The King’s Fund
The underlying argument  seems to 
be that although choice, competition, 
plurality of supply, and devolved 
decision making were the health 
policies eventually reached by 
New Labour, they had never really 
been tried out properly. The market 
had always been constrained and 
a bit half hearted. Choice was 
never a reality for most patients, 
and as for primary care trusts 
as commissioners—total (and 
expensive) failures at their jobs. A 
harsh diagnosis perhaps, but what to 
do to achieve an NHS that “achieves 
results that are among the best in the 
world”?
Much of the prescription is 
essentially to retain the economic 
architecture—for example, choice 
and competition—but to shake up 
the organisational structure: out with 
primary care trusts, strategic health 
authorities, targets, and ministerial 
“meddling”; and in with compulsory 
GP commissioning, an independent 
NHS board, and “outcome goals.” 
Whether you see this as evolution, 
revolution, devolution, or just the 
same old solution depends on your 
point of view—although views seem 
unconventionally split; there are 
ex-Labour health advisers supporting 
the proposals 1 2 and right of centre 
think tanks opposing them.3
The crucial question is whether 
these reforms are a cost effective way 
to achieve better health outcomes 
and more productive use of every 
NHS pound. The main danger is that 
efforts to improve productivity as 
money gets tight will be diffused, 
and the cost of change outweighs the 
value of the benefits. Is this a gamble 
worth taking?
Kambiz Boomla 
senior lecturer, Centre for Health Sciences, 
Queen Mary University of London
The coalition promised us protection 
of NHS budgets with continuing 
growth, and no more major 
reorganisations. Both pledges now 
seem in tatters. We now face the 
largest structural reorganisation the 
NHS has experienced alongside 
NHS chief executive David Nicholson 
asking primary care trusts to find 
£20bn (€23bn; $30bn) of savings 
next year. But GPs are being wooed 
with the prize of being in charge of 
80% of the budget. Is this a gift we 
should be seizing with both hands, 
or would we be wise to heed the 
words of the Trojan priest Laocoon: 
“Beware of Greeks bearing gifts?”
It would have been hard for this 
government, without any democratic 
mandate to do so, to have privatised 
chunks of the NHS in one go. But if 
you combine the promise of “any 
willing provider,” which means 
private sector companies can bid 
for any contract, with “no bailouts 
for organisations which overspend 
public budgets,” it becomes clear 
where these reforms are heading. It is 
unlikely that GP consortiums will be 
so much more efficient than primary 
care trusts in commissioning that 
we will be able to prevent provider 
trusts from overspending their 
budgets, or indeed, stay within our 
own budgets. Perhaps that would 
have been possible before the credit 
crunch, when there was real growth 
in the system, but not now. With 
Monitor as the watchdog, a failure 
regime is being established that will 
allow chunks of the commissioning 
and provider side to be handed over 
to the private sector as the public 
sector fails. This has already started 
in education. Heed the words of that 
Trojan priest.
Professor Peter Davies  
consultant chest physician, Liverpool Heart 
and Chest Hospital
I believe the reorganisation is 
irrelevant to the needs of the health 
service. Its introduction will cause 
temporary harm in the short term as 
managers and clinicians try to find out 
what they should be doing, and in the 
long term it will make little difference.
I believe we have lost the plot when 
it comes to NHS organisation. Once it 
was designed as a top down almost 
paternalistic system with the district 
health authority as the basic building 
block. Money came from central 
government and was distributed 
to hospitals and practices by the 
district health authority according 
to need on the basis of population 
and pathology. It worked, but was 
grossly underfunded. Fire services are 
organised in this way.
In 1990, under Kenneth Clarke, we 
changed from a “fire service” method 
of organisation to a “grocery store” 
type. The district health authority was 
abolished. In its place GPs became 
purchasers and hospitals became 
providers. The internal market arrived 
and was supposed to improve 
services as competition improves 
grocery provision. We had GP 
fundholding practices for a while, but 
they were inefficient and wasteful.
Dealing with patients with diseases 
is not as simple as selling apples 
and cornflakes. Undergraduate, and 
particularly graduate, teaching and 
research do not fit this model.
When increased funding came, 
as it did under Labour, much of the 
benefit was wasted propping up 
this inappropriate model. After 20 
years no political party will admit 
they are wrong and end the failed 
experiment of the internal market.
More brickbats 
than bouquets? 
We asked a range of commentators from clinicians 
to academics to comment on the white paper on 
health Equity and Excellence: Liberating the NHS. 
Has the NHS become “a huge laboratory for some 
dodgy experiments,” will the white paper divide the 
medical profession, or will it empower doctors?  
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Jacky Davis
 co-chair NHS Consultants’ Association 
The white paper is guaranteed to do 
at least three things. It will accelerate 
the commissioning and delivery of 
NHS care by the private sector. It will 
direct blame for the inevitable cuts 
and  closures away from politicians 
towards GPs. Finally, it will divide the 
profession.
The government has been astute. 
It knows that doctors are tired of 
bureaucracy so the phasing out of 
primary care trusts and strategic 
health authorities is attractive, as is 
the prospect of GPs having charge of 
the commissioning budget. Knowing 
this, they have set up a bear trap 
baited with GP commissioning. 
Unfortunately, it seems that the 
bait is so alluring that the  
profession is walking straight into 
the trap.
Commissioning will end up in 
the hands of private companies 
who will buy care from other private 
companies under the “any willing 
provider” agenda. GP consortiums 
will be vulnerable to being bought 
up by the health corporations, as 
they have been in the United States. 
Hospitals will have to become social 
enterprise bodies outside the NHS, 
with loss of national terms and 
conditions and pensions for their 
staff in a short time. NHS staff on 
national terms and conditions will 
rapidly become an endangered 
species. End of the NHS, anyone?
The private sector has already 
acknowledged that this cannot 
happen without GP cooperation. 
But the proposals have no electoral 
mandate, no supporting evidence, 
no consultation, and no pilot. The 
profession should answer “no 
thanks.”
Andy Haines 
professor of public health and primary 
care, London School of Hygiene and 
Tropical Medicine, London
GPs will assume much of the risk at 
a time when, as the government ac-
knowledges, “there are some difficult 
decisions to make.”
Success will be judged not by the 
performance of the best consortiums, 
but by whether the reforms as a 
whole deliver improved outcomes 
with greater efficiency and increased 
equity. Fundholding by general 
practices produced relatively modest 
returns.5 Can a more comprehensive 
involvement yield greater impacts 
while reducing current management 
costs by an arbitrary, but prescribed, 
45%? Given the likely increased 
transaction costs from engagement 
of large numbers of commissioning 
consortiums this is a challenging 
goal. These legitimate questions 
can be answered only by rigorous 
evaluation6 which, given the welcome 
commitment to research and to 
evidence based practice, should be 
built in from the outset. The capacity 
of Monitor to ensure transparent 
pricing and financial accountability as 
well as the NHS Commissioning Board 
to promote quality and support GP 
consortiums will be key to progress.
Proposals for the integration of 
public health into local government 
should provide an opportunity 
to influence the social and 
environmental determinants of health 
through intersectoral action as well 
as much needed coordination of 
health and social care. The proposal 
to create a new public health service 
that includes the responsibility for 
vaccination and screening, however, 
risks separating these from primary 
care.
Finally, it is essential that training 
and education are not subject 
to the vagaries of short term 
commissioning by providers who do 
not have a strategic view of workforce 
requirements. 
David Haslam 
national clinical adviser, Care Quality 
Commission, president elect, BMA
It’s probably a case of “be careful 
what you wish for.” For years, primary 
care leaders have banged the drum 
for an increased focus on their corner 
of the medical world. And now it feels 
as if general practice is being told, 
“Okay, if you’re so smart, you sort it 
out.” Not only do GPs have to deal 
with most of the problems of most of 
the population most of the time, but 
now in England they have to run the 
NHS too.
The white paper should be 
applauded for many things. Patients, 
not the needs of the system, 
should—must—be at the centre 
of all that we do. At last there is an 
attempt to describe what the NHS is 
for. After all, if you can’t define what 
you are trying to do, you can’t tell if 
you are succeeding. And not before 
time it seems that quality, and the 
description, demonstration, and 
measurement of quality, is central to 
policy.
Although the aspirations are 
noble, the devil—as ever—will be in 
the detail. In particular, what might 
the unintended consequences be? 
In the same way that drugs may be 
prescribed with noble intent and yet 
turn out to have unpredicted side 
effects, so can noble policies cause 
unpredictable problems. For instance, 
if experienced GPs, with their ability 
to manage clinical risk, spend more 
of their time on commissioning, will 
referral and prescribing costs escalate 
as inexperienced colleagues see the 
patients?
I wish the white paper well. 
It offers potential for genuine 
improvement, but—as with any form 
of prescription—an understandable 
desire for rapid results may increase 
the degree of risk. Identifying and 
minimising risk isn’t being negative. 
It’s absolutely essential.
David J Hunter
professor of health policy and 
management, Durham University
The changes to the English NHS leave 
no part untouched. Once again, it 
has become a huge laboratory for 
some dodgy experiments. A few good 
things are in prospect, including the 
move of public health to local 
government and an expanded role 
for NICE (National Institute for Health 
and Clinical Excellence). But these 
stand to be eclipsed by other hasty 
and ill conceived proposals.
Handing responsibility for 
commissioning to 500 or so GP 
consortiums is high risk. There is 
no evidence that a reckless shift of 
power and resources on this scale will 
succeed. The evidence from the past 
14 NHS “redisorganisations” suggest 
otherwise. Like GP fundholding in the 
early 1990s, GP commissioning may 
prove to be more of a wild card than a 
winning hand. To claim the changes 
are about culture and not structure 
is disingenuous and flies in the face 
of what is happening as primary care 
trusts wind down.
Putting patients at the heart of 
everything may improve care for 
some, but probably not for all with 
the “inverse care law” becoming 
more entrenched. The principal 
beneficiaries of the changes, apart 
from some enthusiastic GPs, will be 
private healthcare companies already 
circling and ready to swoop to make 
a killing from the NHS’s ringfenced 
budget and, in the process, 
fragmenting services, “gaming” the 
system to cherry pick patients, and 
driving up transaction costs.
Bart Johnson 
chief executive, Assura Medical, 
part owned by Virgin Healthcare
It is easy to be distracted by the 
obvious headline grabbers. But 
taking the white paper as a whole, it is 
clear that the government’s strategic 
reform is focused on developing a 
system of health care where patients 
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are empowered to make informed 
choices about which GP they want to 
register with.
That registration comes with a 
budget for the patient’s entire care, 
indicating that there will be rapid 
evolution of a free market that is 
based on fair and open competition, 
quality and service, with the principal 
aim firmly targeted on improving 
patient outcomes.
Although much of the commentary 
has focused on commissioning, it is 
probable that the most dramatic and 
permanent changes will be around 
provision. Existing and new providers 
will have opportunities to deliver 
services in novel ways, and it is fair 
to expect an increasingly competitive 
marketplace to emerge in which, 
among others, GP led provider 
organisations are ideally placed to 
progress.
Not all GPs will find the transition 
easy. Some will be looking to exit 
partnerships and secure salaried 
positions. Consortiums will look 
inside and outside the NHS for help 
in their new roles. Well established 
companies like Assura Medical, who 
are already working in partnership 
with GPs are likely to be the type of 
organisation GPs turn to.
Robert Lechler
executive director of King’s Health 
Partners
Several features of the white paper 
are to be thoroughly welcomed. 
These include the empowering of 
doctors and patients to influence 
the design of clinical services, the 
commitment to reduce the tiers of 
management with their associated 
costs, and the greater emphasis 
on public health. Perhaps the most 
important shift of emphasis is 
from targets (inputs) to outcomes 
(outputs). Although targets have led 
to improvements in the performance 
of the NHS in several areas, they are 
no substitute for measuring what 
matters most to patients—namely, 
the outcome of their health care. The 
white paper also makes reference 
to the importance of biomedical 
research as an engine of innovation 
in the NHS; given the substantial 
investment in health research 
through the National Institute for 
Health Research, the creation of a 
few biomedical research centres, 
and the competitive accreditation 
of five academic health science 
centres, these centres of excellence 
need to be further supported and 
looked to for leadership and quality 
improvement across the spectrum of 
health care. Two crucial dimensions, 
however, are not explicit in the white 
paper. The first is the importance of 
designing specialist services on the 
basis of evidence, benchmarked 
against the best outcomes in the 
world. This will often lead to the 
concentration of activity in major 
centres, creating the volume of 
activity that allows the highest 
quality results. This approach has 
guided the rationalisation of several 
major specialist services in London 
during the implementation of the 
Darzi reforms.
The second is the development 
of models of integrated health care, 
dissolving the primary-secondary 
care divide. Such integration has 
the potential to improve outcomes, 
particularly for patients with chronic 
diseases, to improve patient 
satisfaction, and to reduce costs. 
Most importantly, if funded by a 
capitation based model, integrated 
care systems transfer the incentive 
to keeping people healthy and 
promoting population health, rather 
than rewarding clinical activity. 
Judith Lindeck
general practitioner, Cambridgeshire
My initial thoughts are that this could 
be good and that the proposed 
consortiums feel like the old primary 
care groups or primary care trusts, 
which seemed to work well in Bristol 
where I used to work.
But here in Cambridge will it 
change anything? We have one large 
“multinational” hospital in town—
effectively a monopoly provider.
The experience with a local 
practice based commissioning group 
was that our hospital was unlikely to 
help us set up alternatives to their 
service unless it suited them. After 
all it would reduce their funding, and 
without secondary care cooperation 
a community service might be unsafe 
or unusable.
Negotiating contracts with a 
monopoly doesn’t work. They will 
certainly not reduce their prices if 
they have a guaranteed workload. 
If the consortium doesn’t pay the 
patients won’t get treated. If the 
consortium goes into the red, then 
what? No health care for Cambridge? 
The white paper doesn’t explain.
If patients have the choice of 
where they go and who they see, 
most will choose the local hospital. 
Why travel 17 miles when you have 
a “world class” hospital on your 
doorstep? The primary care group 
has set up alternative endoscopy 
and radiography services in a 
neighbouring town, but the patients 
won’t travel that far, even if parking 
is free.
In Bristol there are four hospitals 
within easy reach, and patients 
are happy to travel between them 
so I can see how in big cities these 
reforms could work well. In small 
cities and towns it’s hard to see how 
any commissioning consortiums 
could do more than tweak the edges. 
We might save a little here and there, 
but not enough to make the amount 
of time that is lost worth while.
Allyson Pollock
professor of international public health 
policy, Edinburgh University
The NHS in England is to be 
dismantled and instead health 
care will be run on US healthcare 
lines. If this paper is enacted then 
for the first time in 60 years the 
citizens of England will experience 
a return to fear. The hallmark of our 
health service is public funding 
raised through general taxation; 
public ownership, and public 
accountability for services; and area 
based planning and allocation of 
resources for services delivered on 
the basis of need and not ability 
to pay. But unlike Scotland and 
Wales, which have reversed market 
oriented changes, successive English 
governments have eroded the 
foundations of the NHS in England, 
paving the way for market and profit 
oriented health care to introduce 
private “for profit” elements into 
clinical care.
And now, with neither an electoral 
nor a moral mandate, the legal 
duty of the secretary of state to 
provide universal care to the whole 
population on the basis of need and 
not ability to pay is to be abolished. 
The NHS will be reduced to simply 
being the government payer and 
patients and staff exposed to the 
full weight of market forces. GPs do 
not have professional training or 
experience in health service planning 
let alone commissioning; meanwhile 
the private for profit sector and 
multinational healthcare companies 
are lining up to take control of 
the £80bn (€95bn; $123bn) of 
NHS resources. The BMA and all 
doctors must not let the NHS go 
undefended—and neither should the 
citizens of England.
Ann McPherson
medical director, DIPEx Health 
Experiences Research Group, University 
of Oxford
Much in the white paper cannot be 
questioned. The positives are: it 
gives high value to patients’ views of 
the services, it says that it upholds 
the values and principles of the 
NHS, it continues to support quality 
standards developed by NICE to 
inform commissioning, and it has the 
ambition  to provide a world class 
service. It also highlights the need to 
increasingly take account of patient 
experiences. One thing is certain—
yet another reorganisation will use 
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money that could be better spent 
on patient services, and waste a 
huge amount of professional clinical 
time which could be better spent on 
patient care.
But why this endless 
concentration on “choice,’’ which I 
think is a distraction and a “catch all” 
word? As a long time GP requiring 
considerable personal medical care 
myself— choice has been low on my 
list of priorities. What I have certainly 
wanted, and what my patients have 
told me that they want, is good 
evidence based, quality care that is 
near home. This means well informed 
and understanding GPs and a good 
local hospital with short waiting 
lists (something that targets have 
achieved).
I am sceptical that 500 or so GP 
consortiums commissioning services 
will save money or result in better 
patient care, let alone provide more 
efficient planning of appropriate 
services. They will probably further 
open the door to private enterprises, 
which will initially offer services 
cheaply as lost leaders, along with 
inducements to GPs to commission 
their services, and then tighten the 
financial screws to ensure they make 
greater profits. Is this where the NHS 
should be going?
Gayathri Rabindra
general practitioner trainee, Sidcup, 
London Deanery
GPs currently do some 
commissioning, and a few 
consortiums are around. As a GP 
trainee I find the proposed changes 
both exciting and terrifying. In theory, 
we do know more than the managers 
about what our patients want and 
need. We are not trained as experts 
in commissioning and planning 
services, however, so is it right to 
give such a big responsibility to us? 
Having worked in a primary care trust, 
I have seen the amount of work and 
time that goes into this: researching 
the diseases in a population, what 
the current services are, what 
national guidelines are, what the 
population wants. Can all this really 
be scrapped and GPs expected to do 
it on top of their usual jobs? Won’t it 
take GPs away from patient care? The 
main thing that patients always want 
is more access to their GP.
Simon Stevens
president of global health at UnitedHealth 
Group, and a trustee of the King’s Fund
What’s not to like about the new 
NHS white paper? Certainly there are 
risks. Can local GP commissioning 
consortiums be effective in every part 
of the country—and, if not, what’s the 
fall back plan? How will the transition 
of all NHS hospitals to the foundation 
trust “liberated zone” fare? Will 
the proposed regulatory division 
of labour between Monitor, Care 
Quality Commission, and the new 
commissioning board work?
But history suggests it is budget 
crunches, not system reforms, 
which generate the NHS’s existential 
crises—in 1951, 1968, 1976, 1987-
8, and 1999.7 This parliament will 
see an unprecedented NHS funding 
deceleration—with Labour unusually 
arguing that the centre-right coalition 
should impose deeper NHS cuts.8 9
So the key judgment call is: 
which policy regime is best suited 
to safeguard and improve patient 
care under these new conditions 
of austerity? Central diktat, or an 
approach that increasingly relies 
on patient empowerment, local 
professional judgment, and greater 
provider dynamism?
Some people will assert the latter 
path is a ploy to “destroy the NHS.” 
Similarly apocalyptic, but ultimately 
spurious, prophecies date back 
at least three decades.10-13 The 
inconvenient truth is that on most 
key indicators the English NHS is 
probably performing better than 
ever.14-17
Others would simply prefer a 
halt to further structural change. 
The paradox is that it is the NHS 
tax funded status and consequent 
national political control, which NHS 
loyalists admire, that in turn cause 
the stop go budgeting and top down 
reorganisations, which they lament. 
Sixty years of accumulated evidence 
indicates that praising the NHS, while 
attacking these intrinsic realities, is 
as futile as fishermen cursing the 
sea.
Richard Thompson
president, Royal College of Physicians
Andrew Lansley is not a timid man. 
To secure his reforms he proposes 
to overhaul, at tremendous speed, 
the entire basis on which the NHS 
is organised. Placing responsibility 
for commissioning with GPs, and 
scrapping many of the centrally 
managed performance targets 
brings numerous risks and costs, 
but also opportunities.
Any hospital doctor who has 
spent time trying to explain their 
service to a non-clinically trained 
commissioner will rejoice at the 
thought of being able to talk directly 
with their new GP commissioner. 
Conversely, GPs are well placed to 
evaluate services. So long as the 
relationships are characterised by 
the courteous scepticism that only 
members of the same profession 
can display towards one another, 
this has the potential to be an 
important lever for quality.
Nevertheless, we should not 
underestimate the task facing 
our primary care colleagues. Few 
will start the job with experience 
of developing whole-population 
strategies, nor be fully prepared for 
the necessary change in mindset. 
It is also disappointing that more is 
not said in the white paper about 
integrating primary and secondary 
care. Effective management of the 
growing chronic disease burden 
will require GPs and their specialist 
colleagues to collaborate more 
closely if their shared patients are 
to see the right person, in the right 
place, and at the right time. 
Jonathan Waxman
professor of oncology, Imperial College 
London
 The white paper is a finely written 
piece of prose redolent with allegory 
and metaphor that comes straight 
from a copywriter’s posterior. It 
proposes joined up, radical change to 
the way the NHS is managed and will 
empower the professionals . . . well 
some of them, the GPs. The trouble is 
that the white paper doesn’t seem to 
be written by an empowered joined 
up professional, and so lacks insight 
into the way the NHS works. It shows 
little understanding that health care 
is complex and doesn’t just involve 
one group of doctors, but many 
professional groups working together.
It seems that the notional cost of 
introducing these proposed changes 
is £1.7bn (€2bn; $2.6bn). We know 
that government costing estimates 
are born in ya ya land, and usually out 
by a factor of 10 or 100, or whatever. 
We have seen the £15bn disaster of 
the NHS computer costs. The primary 
care trusts were introduced without 
trialling, and they have been a mess 
that costs £5bn a year to administer. 
The NHS is a £100bn business. What 
type of business introduces change 
of the order that the government is 
proposing without trialling? Don’t you 
think we should think about things 
before we leap off the white cliffs into 
the savage sea and on to the razor 
rocks?
The current white paper sets one 
group of health providers against 
another. It claims to be joined up, 
but it is divisive and potentially 
destructive. Please minister, think 
again.
See EDITORIAL, p 211
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